Stephane Peluso is Chief Scientific Officer of INFINITY PHARMACEUTICALS, INC.. Currently has a direct ownership of 37,052 shares of INFI, which is worth approximately $0. The most recent transaction as insider was on Aug 02, 2022, when has been sold 14,994 shares (Common Stock) at a price of $0.66 per share, resulting in proceeds of $9,896. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.1K
0% 3M change
0% 12M change
Total Value Held $0

Stephane Peluso Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2022
BUY
Open market or private sale
$9,896 $0.66 p/Share
14,994 Added 28.81%
37,052 Common Stock
Aug 02 2022
BUY
Exercise of conversion of derivative security
-
50,000 Added 49.0%
52,046 Common Stock
SP

Stephane Peluso

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on INFI

Follow INFINITY PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INFI shares.

Notify only if

Insider Trading

Get notified when an Infinity Pharmaceuticals, Inc. insider buys or sells INFI shares.

Notify only if

News

Receive news related to INFINITY PHARMACEUTICALS, INC.

Track Activities on INFI